CUSIP No. 89616C201
Item 1. Security and Issuer
This Amended Statement of Beneficial Ownership on Schedule 13D (“Amendment 5”) amends and supplements the Statement of Beneficial Ownership on Schedule 13D filed by Fengate Trident LP, Fengate Trident GP Inc., and Fengate Capital Management Ltd. (collectively, the “Reporting Persons”) on May 8, 2017 (the “Initial Schedule 13D”), the Amended Schedule 13D filed by the Reporting Persons on September 14, 2017 (“Amendment 1”), the Amended Schedule 13D filed by the Reporting Persons on September 18, 2017 (“Amendment 2”), the Amended Schedule 13D filed by the Reporting Persons on November 5, 2019 (“Amendment 3”), and the Amended Schedule 13D filed by the Reporting Persons on November 12, 2019 (“Amendment 4”) in connection with the parties and matters referenced therein and herein, with respect to the Common Stock, $.001 par value (the “Common Stock”) of Trident Brands, Inc. (the “Issuer”). This Schedule 13D is being filed as a result of the events described in Item 4 below. Any capitalized terms used and not defined in this Amendment 5 shall have the meanings set forth in the Initial Schedule 13D, Amendment 1, Amendment 2, Amendment 3 and/or Amendment 4. Only those items that are hereby reported are amended; all other items, including previously filed exhibits, remain unchanged and are incorporated by reference herein.
Item 3. Source and Amount of Funds or Other Consideration
The Common Stock reported in this Amendment 5 includes 2,811,886.44 shares of Common Stock beneficially owned by the Reporting Persons and additional shares of Common Stock that may be issued to the Reporting Persons upon conversion of certain Convertible Notes, as defined below. As of March 13, 2020, the Reporting Persons had acquired from the Issuer Convertible Notes in an aggregate principal amount of $22,300,000 and the total accrued but unpaid interest on such Convertible Notes, as of March 13, 2020 was $4,098,877. None of the shares of Common Stock or Convertible Notes were acquired on margin, or otherwise using borrowed funds or pursuant to any loan or credit arrangement.
Item 4. Purpose of Transaction
The Common Stock and Convertible Notes have been acquired for investment purposes in the ordinary course of the Reporting Persons’ investment activities, and have not been acquired with any purpose of, or with the effect of, changing or influencing the control of the Issuer, or in connection with or as a participant in any transaction having such purpose or effect. From time to time the Reporting Persons may acquire additional securities of the Issuer, or sell securities of the Issuer. In addition to the transactions reported in the Initial Schedule 13D, Amendment 1, Amendment 2, Amendment 3 and Amendment 4, the following has occurred:
On January 9, 2020 Trident Brands, Inc. (the “Company”) and Fengate Trident LP (“Purchaser”) entered into an Amendment to Convertible Promissory Notes Agreement (“Notes Amendment 1”) to amend the terms of certain convertible promissory notes issued pursuant to a Securities Purchase Agreement by and between the Company and the Purchaser dated September 26, 2016and previously amended on November 30, 2018and March 11, 2019. Amendment 1 affects the convertible notes issued February 5, 2015 (US$1,800,000), May 14, 2015 (US$500,000), September 26, 2016 (US$4,100,000), May 9, 2017 (US$4,400,000) and May 16, 2018 (US$1,500,000), respectively (collectively the “2016 Notes”). Pursuant to Notes Amendment 1, the Purchaser agreed to convert all of the 2016 Notes on or before the earlier of (i) the Maturity Date of the 2016 Convertible Notes and (ii) the Company raising new equity investment of not less than US$2,000,000, on terms mutually acceptable to the Purchaser and the Company (subject to regulatory considerations applicable to the purchaser). Conversion of the 2016 Notes will occur in a single conversion transaction at a price that is equal to a 25% discount to the average closing price of the Company’s common stock for the 10 trading days immediately prior to the conversion date, with the exact structure of the conversion to be determined by the parties. Notes Amendment 1 also amended the outstanding convertible notes issued to the Purchaser on November 30, 2018 (US$3,400,780), April 13, 2019 (US$2,804,187) and November 6, 2019 (US$3,795,033) respectively (collectively the “Amended SPA Notes”). Maturity of the Amended SPA Notes has been deferred to December 1, 2021. It was further agreed that interest on the Amended SPA Notes will accrue as at July 1, 2020 and be payable upon maturity.
A copy of Notes Amendment 1 was attached as Exhibit 10.1 to the Current Report on Form8-K/A, Amendment No.1, filed by the Issuer on January 23, 2020 and is incorporated by reference in this Amendment 5 and as Exhibit 99.2 hereto.
On March 6, 2020, the Parties entered into an agreement (“Notes Amendment 2”) pursuant to which the Reporting Persons agreed to fund in cash $936,167.66 previously withheld from the purchase price of the Additional Convertible Notes (as defined in Amendments 3 and described in Amendment 4) purchased from the Issuer on November 6, 2019. Notes Amendment 2 also amended the “Issuance Date” of that portion of the Principal Amount of the Additional Convertible Notes reflected by the aforementioned $936,167.66 from November 6, 2019 to March 12, 2020.
A copy of Notes Amendment 2 is attached as Exhibit 99.3 hereto.
As of the date of this Amendment 5, the Reporting Persons have no plans or proposals which relate to or would result in (i) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (ii) a sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (iii) any change in the present board of directors